Lead poisoning and its clinical manifestation in opium users: a case series
6 affiliations
- 1Department of Epidemiology, School of Health Sciences, Shiraz University of Medical Sciences, Shiraz, Iran
- 2Faculty of Medicine, Islamic Azad University, Kazerun, Iran
- 3Department of Occupational Health and Safety Engineering, Shiraz University of Medical Sciences, Shiraz, Iran
- 4Research Center for Social Determinants of Health, Jahrom University of Medical Sciences, Jahrom, Iran
- 5Department of Neural Science, College of Arts and Science, New York University, New York, NY USA
- 6Non-Communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract
Background: The practice of adding lead to opium to increase its weight resulted in lead poisoning among opium user, especially those who consume it orally. This study aims to examine patients with symptoms of lead poisoning who are opium users.
Case presentation: We retrospectively investigated the records of 20 Iranian patients who were opium users and presented with symptoms and signs of lead poisoning. Regarding the route of opium administration, 3 patients (15%) reported smoking only, 2 patients (10%) reported oral ingestion only, and the majority of cases (15 patients, 75%) reported combined use of smoking and oral ingestion. All were married and 85% were male, with a mean age of 57.8. The average duration of opium dependence was 19.7 years, with a mean daily consumption of 2.1 g. They reported severe abdominal pain, with or without central nervous system symptoms. Blood lead levels in the patients ranged from 30 to 833 µg/dL, with two patients exceeding 600 µg/dL. Chelation therapy was used for 80% of patients, resulting in 45% having full recovery, 40% partial recovery, and a fatality rate of 15%.
Conclusions: This case series emphasizes the importance of awareness among both opium users and medical staff regarding the risks related to lead poisoning due to contaminated opium. Patients should be informed about the potential contamination of opium, which can cause serious gastrointestinal and neurological symptoms, and even death. Healthcare providers should maintain a high index of suspicion for lead poisoning in opium-addicted patients presenting with compatible symptoms, ensuring early diagnosis and timely treatment, such as chelation therapy.
Related
- Fatal plant poisoning cases in Tunisia: a retrospective series.
- Avermectin poisoning with panic-like symptoms: a case series
- Lymphedema as an initial manifestation of paraneoplastic rheumatic syndromes: a case series of six patients
- Clinical context enhances interpretation of extracorporeal treatment criteria in lithium poisoning
- Tropatepine poisoning and management: a series of 458 cases
BibTeX
@article{baberi2026lead,
title = {{Lead poisoning and its clinical manifestation in opium users: a case series}},
author = {Fatemeh Baberi and Sayed Aliakbar Banihashemi and Saeed Yousefinejad and Fatemeh Rezaei and Saba Sahraian and Alireza Mirahmadizadeh},
journal = {Journal of Medical Case Reports},
year = {2026},
month = oct,
doi = {10.1186/s13256-026-06419-8},
url = {https://doi.org/10.1186/s13256-026-06419-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Lead poisoning and its clinical manifestation in opium users: a case series
AU - Fatemeh Baberi
AU - Sayed Aliakbar Banihashemi
AU - Saeed Yousefinejad
AU - Fatemeh Rezaei
AU - Saba Sahraian
AU - Alireza Mirahmadizadeh
PY - 2026
DA - 2026/10/29
JO - Journal of Medical Case Reports
DO - 10.1186/s13256-026-06419-8
UR - https://doi.org/10.1186/s13256-026-06419-8
AB - Background: The practice of adding lead to opium to increase its weight resulted in lead poisoning among opium user, especially those who consume it orally. This study aims to examine patients with symptoms of lead poisoning who are opium users. Case presentation: We retrospectively investigated the records of 20 Iranian patients who were opium users and presented with symptoms and signs of lead poisoning. Regarding the route of opium administration, 3 patients (15%) reported smoking only, 2 patients (10%) reported oral ingestion only, and the majority of cases (15 patients, 75%) reported combined use of smoking and oral ingestion. All were married and 85% were male, with a mean age of 57.8. The average duration of opium dependence was 19.7 years, with a mean daily consumption of 2.1 g. They reported severe abdominal pain, with or without central nervous system symptoms. Blood lead levels in the patients ranged from 30 to 833 µg/dL, with two patients exceeding 600 µg/dL. Chelation therapy was used for 80% of patients, resulting in 45% having full recovery, 40% partial recovery, and a fatality rate of 15%. Conclusions: This case series emphasizes the importance of awareness among both opium users and medical staff regarding the risks related to lead poisoning due to contaminated opium. Patients should be informed about the potential contamination of opium, which can cause serious gastrointestinal and neurological symptoms, and even death. Healthcare providers should maintain a high index of suspicion for lead poisoning in opium-addicted patients presenting with compatible symptoms, ensuring early diagnosis and timely treatment, such as chelation therapy.
SN - 1752-1947
ER -